AbbVie & MBC BioLabs invite you to apply for the 2020 AbbVie Golden Ticket

The AbbVie Golden Ticket will be awarded to an early stage company developing novel, transformational therapies for autoimmune, oncology, or neurodegenerative disease.

The winner will receive:

Priority admission or renewal for one year’s use of a lab bench and core facilities at MBC BioLabs’ San Francisco or San Carlos site

Opportunities to engage with AbbVie scientific and business leaders

To apply, send your non-confidential company presentation to Semi-finalists will be invited for an in-person presentation at MBC BioLabs in April.

Deadline to apply: FEB 10